In addition, investigators developed a transgenic Drosophila AD model to explore the therapeutic potential of Lisosan G. They demonstrated that Lisosan G ameliorated the tau-induced neurodegenerative symptoms (Bongiorni et al., 2024). Here, MAPT is linked to Alzheimer disease.